AB 555
Establishes provisions relating to the coverage of prescription insulin drugs under certain policies of health insurance. (BDR 57-1167)
Take action
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed Assembly
- Passed Senate
- To Governor
- Became Law
Bill overview
This bill aims to make prescription insulin drugs more affordable for Nevada residents by limiting the cost-sharing (like deductibles and copays) that private health insurers can charge for a 30-day supply. It sets a maximum cost-sharing amount of $35, while also clarifying certain insurer practices and authorizing the state insurance commissioner to ensure compliance. The bill also includes provisions to address coverage for Medicaid recipients and government employees.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.